Cargando…
Corrigendum: Network pharmacology integrated with experimental validation to explore the therapeutic role and potential mechanism of Epimedium for spinal cord injury
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10411349/ https://www.ncbi.nlm.nih.gov/pubmed/37564784 http://dx.doi.org/10.3389/fnmol.2023.1257836 |
_version_ | 1785086646082863104 |
---|---|
author | Fu, Xuanhao Ma, Boyuan Zhou, Mengmeng Cheng, Yuelin Liu, Linyan Kan, Shunli Liu, Chengjiang Zhao, Xinyan Feng, Sa Zhu, Haoqiang Hu, Wei Jiang, Zehua Zhu, Rusen |
author_facet | Fu, Xuanhao Ma, Boyuan Zhou, Mengmeng Cheng, Yuelin Liu, Linyan Kan, Shunli Liu, Chengjiang Zhao, Xinyan Feng, Sa Zhu, Haoqiang Hu, Wei Jiang, Zehua Zhu, Rusen |
author_sort | Fu, Xuanhao |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10411349 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-104113492023-08-10 Corrigendum: Network pharmacology integrated with experimental validation to explore the therapeutic role and potential mechanism of Epimedium for spinal cord injury Fu, Xuanhao Ma, Boyuan Zhou, Mengmeng Cheng, Yuelin Liu, Linyan Kan, Shunli Liu, Chengjiang Zhao, Xinyan Feng, Sa Zhu, Haoqiang Hu, Wei Jiang, Zehua Zhu, Rusen Front Mol Neurosci Molecular Neuroscience Frontiers Media S.A. 2023-07-26 /pmc/articles/PMC10411349/ /pubmed/37564784 http://dx.doi.org/10.3389/fnmol.2023.1257836 Text en Copyright © 2023 Fu, Ma, Zhou, Cheng, Liu, Kan, Liu, Zhao, Feng, Zhu, Hu, Jiang and Zhu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Molecular Neuroscience Fu, Xuanhao Ma, Boyuan Zhou, Mengmeng Cheng, Yuelin Liu, Linyan Kan, Shunli Liu, Chengjiang Zhao, Xinyan Feng, Sa Zhu, Haoqiang Hu, Wei Jiang, Zehua Zhu, Rusen Corrigendum: Network pharmacology integrated with experimental validation to explore the therapeutic role and potential mechanism of Epimedium for spinal cord injury |
title | Corrigendum: Network pharmacology integrated with experimental validation to explore the therapeutic role and potential mechanism of Epimedium for spinal cord injury |
title_full | Corrigendum: Network pharmacology integrated with experimental validation to explore the therapeutic role and potential mechanism of Epimedium for spinal cord injury |
title_fullStr | Corrigendum: Network pharmacology integrated with experimental validation to explore the therapeutic role and potential mechanism of Epimedium for spinal cord injury |
title_full_unstemmed | Corrigendum: Network pharmacology integrated with experimental validation to explore the therapeutic role and potential mechanism of Epimedium for spinal cord injury |
title_short | Corrigendum: Network pharmacology integrated with experimental validation to explore the therapeutic role and potential mechanism of Epimedium for spinal cord injury |
title_sort | corrigendum: network pharmacology integrated with experimental validation to explore the therapeutic role and potential mechanism of epimedium for spinal cord injury |
topic | Molecular Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10411349/ https://www.ncbi.nlm.nih.gov/pubmed/37564784 http://dx.doi.org/10.3389/fnmol.2023.1257836 |
work_keys_str_mv | AT fuxuanhao corrigendumnetworkpharmacologyintegratedwithexperimentalvalidationtoexplorethetherapeuticroleandpotentialmechanismofepimediumforspinalcordinjury AT maboyuan corrigendumnetworkpharmacologyintegratedwithexperimentalvalidationtoexplorethetherapeuticroleandpotentialmechanismofepimediumforspinalcordinjury AT zhoumengmeng corrigendumnetworkpharmacologyintegratedwithexperimentalvalidationtoexplorethetherapeuticroleandpotentialmechanismofepimediumforspinalcordinjury AT chengyuelin corrigendumnetworkpharmacologyintegratedwithexperimentalvalidationtoexplorethetherapeuticroleandpotentialmechanismofepimediumforspinalcordinjury AT liulinyan corrigendumnetworkpharmacologyintegratedwithexperimentalvalidationtoexplorethetherapeuticroleandpotentialmechanismofepimediumforspinalcordinjury AT kanshunli corrigendumnetworkpharmacologyintegratedwithexperimentalvalidationtoexplorethetherapeuticroleandpotentialmechanismofepimediumforspinalcordinjury AT liuchengjiang corrigendumnetworkpharmacologyintegratedwithexperimentalvalidationtoexplorethetherapeuticroleandpotentialmechanismofepimediumforspinalcordinjury AT zhaoxinyan corrigendumnetworkpharmacologyintegratedwithexperimentalvalidationtoexplorethetherapeuticroleandpotentialmechanismofepimediumforspinalcordinjury AT fengsa corrigendumnetworkpharmacologyintegratedwithexperimentalvalidationtoexplorethetherapeuticroleandpotentialmechanismofepimediumforspinalcordinjury AT zhuhaoqiang corrigendumnetworkpharmacologyintegratedwithexperimentalvalidationtoexplorethetherapeuticroleandpotentialmechanismofepimediumforspinalcordinjury AT huwei corrigendumnetworkpharmacologyintegratedwithexperimentalvalidationtoexplorethetherapeuticroleandpotentialmechanismofepimediumforspinalcordinjury AT jiangzehua corrigendumnetworkpharmacologyintegratedwithexperimentalvalidationtoexplorethetherapeuticroleandpotentialmechanismofepimediumforspinalcordinjury AT zhurusen corrigendumnetworkpharmacologyintegratedwithexperimentalvalidationtoexplorethetherapeuticroleandpotentialmechanismofepimediumforspinalcordinjury |